Literature DB >> 16901283

Absence of HCV viral recombination following superinfection.

F Bernardin1, B Herring, K Page-Shafer, C Kuiken, E Delwart.   

Abstract

We sought evidence of viral recombination in five recently hepatitis C virus (HCV) infected young injection drug users who became superinfected with a distinguishable strain of HCV. The entire open reading frame of plasma HCV genomes was reverse transcribed, polymerase chain reaction amplified in two fragments, and directly sequenced. In two cases of same subtype (1a > 1a) superinfections the initial and later strains were both sequenced and compared for evidence of recombination. In three cases of superinfection with strains of different genotype/subtype (3a > 1a, 1a > 3a, 1b > 1a), the later time point HCV genomes were sequenced and compared with representative genomes of the initial genotype/subtype. No evidence of intra- or inter-genotype/subtype recombination was detected using six different programs for detecting recombination. We conclude that the generation of viable recombinant HCV genomes able to dominate in the viral quasispecies is a rare event.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901283     DOI: 10.1111/j.1365-2893.2006.00722.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

1.  Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.

Authors:  Xiao-Hong Wang; Dale M Netski; Jacquie Astemborski; Shruti H Mehta; Michael S Torbenson; David L Thomas; Stuart C Ray
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

2.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

3.  A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.

Authors:  Bambang S Adiwijaya; Eva Herrmann; Brian Hare; Tara Kieffer; Chao Lin; Ann D Kwong; Varun Garg; John C R Randle; Christoph Sarrazin; Stefan Zeuzem; Paul R Caron
Journal:  PLoS Comput Biol       Date:  2010-04-15       Impact factor: 4.475

4.  High levels of subgenomic HCV plasma RNA in immunosilent infections.

Authors:  Flavien Bernardin; Susan L Stramer; Barbara Rehermann; Kimberly Page-Shafer; Stewart Cooper; David R Bangsberg; Judith Hahn; Leslie Tobler; Michael Busch; Eric Delwart
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

Review 5.  Recombination in hepatitis C virus.

Authors:  Fernando González-Candelas; F Xavier López-Labrador; María Alma Bracho
Journal:  Viruses       Date:  2011-10-24       Impact factor: 5.048

6.  Evidence of recombination in intrapatient populations of hepatitis C virus.

Authors:  Vicente Sentandreu; Nuria Jiménez-Hernández; Manuela Torres-Puente; María Alma Bracho; Ana Valero; María José Gosalbes; Enrique Ortega; Andrés Moya; Fernando González-Candelas
Journal:  PLoS One       Date:  2008-09-18       Impact factor: 3.240

7.  Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient.

Authors:  John Aaskov; Katie Buzacott; Emma Field; Kym Lowry; Alain Berlioz-Arthaud; Edward C Holmes
Journal:  J Gen Virol       Date:  2007-12       Impact factor: 3.891

8.  Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico.

Authors:  Gerardo Perez-Ramirez; Alvaro Diaz-Badillo; Minerva Camacho-Nuez; Alejandro Cisneros; Maria de Lourdes Munoz
Journal:  BMC Microbiol       Date:  2009-12-15       Impact factor: 3.605

9.  Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing.

Authors:  Hui Li; Mark B Stoddard; Shuyi Wang; Lily M Blair; Elena E Giorgi; Erica H Parrish; Gerald H Learn; Peter Hraber; Paul A Goepfert; Michael S Saag; Thomas N Denny; Barton F Haynes; Beatrice H Hahn; Ruy M Ribeiro; Alan S Perelson; Bette T Korber; Tanmoy Bhattacharya; George M Shaw
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.